<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Noninvasive Electrocardiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Noninvasive Electrocardiol</journal-id>
      <journal-id journal-id-type="publisher-id">anec</journal-id>
      <journal-title-group>
        <journal-title>Annals of Noninvasive Electrocardiology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1082-720X</issn>
      <issn pub-type="epub">1542-474X</issn>
      <publisher>
        <publisher-name>BlackWell Publishing Ltd</publisher-name>
        <publisher-loc>Oxford, UK</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24708271</article-id>
      <article-id pub-id-type="pmc">4544285</article-id>
      <article-id pub-id-type="doi">10.1111/anec.12085</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Reports</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sustained Ventricular Tachycardia in a Patient with Thalassemia Major</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bayar</surname>
            <given-names>Nermin</given-names>
          </name>
          <degrees>M.D</degrees>
          <xref ref-type="aff" rid="au1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arslan</surname>
            <given-names>&#x15E;akir</given-names>
          </name>
          <degrees>M.D</degrees>
          <xref ref-type="aff" rid="au1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Erkal</surname>
            <given-names>Zehra</given-names>
          </name>
          <degrees>M.D</degrees>
          <xref ref-type="aff" rid="au1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>K&#xFC;&#xE7;&#xFC;kseymen</surname>
            <given-names>Sel&#xE7;uk</given-names>
          </name>
          <degrees>M.D</degrees>
          <xref ref-type="aff" rid="au1"/>
        </contrib>
        <aff id="au1">
          <institution>Antalya Education And Research Hospital, Cardiology Department</institution>
          <addr-line>Antalya, Turkey</addr-line>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">
Address for correspondence: Nermin Bayar, M.D., Antalya Education and Research Hospital, Cardiology Department, Antalya, Turkey. E-mail: <email>dr.nermin@mynet.com</email>; Tel: +90 505 400 75 09
</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>09</day>
        <month>9</month>
        <year>2013</year>
      </pub-date>
      <volume>19</volume>
      <issue>2</issue>
      <fpage>193</fpage>
      <lpage>197</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2013 The Author(s)</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>electrophysiology&#x2013;ventricular tachycardia</kwd>
        <kwd>clinical, implantable devices&#x2013;ventricular tachycardia/fibrillation</kwd>
        <kwd>clinical</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Although improvements in the treatment of thalassemia with transfusion and chelation therapy have been achieved, iron overload because of repeated red blood cell transfusions continue to cause organ dysfunction. The prognosis is determined by the degree of involvement of heart disease, mortality in these patients is mainly because of heart failure.<xref rid="b1" ref-type="bibr">1</xref> In this case, cardiac hemosiderosis due to thalassemia and admitted to our Emergency Room with ventricular tachycardia with hemodynamic disrupts, then have implantable cardioverter defibrillator (ICD), 30-year-old male patient is presented. This is the first report among the thalassemia patients, presented with ventricular tachycardia based on literature search.</p>
    <sec>
      <title>CASE REPORT</title>
      <p>Thirty-year-old male patient, who followed with a diagnosis of &#x3B2;-thalassemia major, was admitted to the emergency room with palpitations and chest tightness before half an hour. There was a history of blood cell transfusion for thalassemia since the age, 8 years old began to deferoxamine, 10-year-old splenectomy was performed and before 4 months was started deferiprone in addition to deferoxamine. There was increase in dyspnea and palpitation in the past few months. During the application, blood pressure was 90/50 mm Hg, the pulse 176/minute, an electrocardiogram showed wide-complex tachycardia (Fig.<xref ref-type="fig" rid="fig01">1</xref>). The patient initially received intravenous amiodarone (300 mg/30 min) and transfered to coronary intensive-care unit. 15th minute of infusion, the patient became hypotensive and hemodynamically unstable, lost consciousness, pulseless ventricular tachycardia (VT) were defibrillated with 200 joules and sinus rhythm was achieved (Fig.<xref ref-type="fig" rid="fig02">2</xref>). Then installation of intravenous amiodarone was completed and the maintenance of oral treatment was passed, metoprolol 50 mg/day and ramipril 2.5 mg/day was administered. Transthoracic echocardiography revealed normal left ventricular systolic function, left ventricular hypertrophy and diastolic <italic>dysfunction</italic> have a <italic>restrictive filling</italic> pattern (Figs.<xref ref-type="fig" rid="fig03">3</xref>, <xref ref-type="fig" rid="fig04">4</xref>, and <xref ref-type="fig" rid="fig05">5</xref>). The hemogram reveals profound anemia with a hemoglobin level of 8.4 g/dL, diluted ferritin was 1300 ng/mL, thyroid hormones, electrolyte levels and cardiac enzymes were normal. Erythrocyte suspension were given the suggestion of hematology clinic, chelation therapy was continued. The patient was taken to control ventricular arrhythmias with amiodarone, ICD implantation was performed for the purpose of secondary prevention. Patient's ECG, has viewed repolarization changes during follow-up (Fig.<xref ref-type="fig" rid="fig06">6</xref>). Follow-up of patient without complication and was discharged with metoprolol and amiodarone therapy.</p>
      <fig id="fig01" position="float">
        <label>Figure 1</label>
        <caption>
          <p>ECG on admission to emergency department.</p>
        </caption>
        <graphic xlink:href="anec0019-0193-f1"/>
      </fig>
      <fig id="fig02" position="float">
        <label>Figure 2</label>
        <caption>
          <p>ECG after being defibrillated.</p>
        </caption>
        <graphic xlink:href="anec0019-0193-f2"/>
      </fig>
      <fig id="fig03" position="float">
        <label>Figure 3</label>
        <caption>
          <p>M-mode imaging, the left ventricular dimensions and ejection fraction were normal.</p>
        </caption>
        <graphic xlink:href="anec0019-0193-f3"/>
      </fig>
      <fig id="fig04" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Mitral E/A ratio were above 2.</p>
        </caption>
        <graphic xlink:href="anec0019-0193-f4"/>
      </fig>
      <fig id="fig05" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Mitral E&#x2032; value is below 8 ms and consistent with restrictive type diastolic dysfunction.</p>
        </caption>
        <graphic xlink:href="anec0019-0193-f5"/>
      </fig>
      <fig id="fig06" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Patient's ECG, has viewed repolarization changes during follow-up.</p>
        </caption>
        <graphic xlink:href="anec0019-0193-f6"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>&#x3B2;-thalassemia is an inherited blood disease caused by mutations leading to reduction or absence of the &#x3B2;-globin chain production.<xref rid="b2" ref-type="bibr">2</xref> Clinical features of &#x3B2;-thalassemia include haemolytic and hyperchromic anemia, ineffective erythropoiesis that causes profound anemia. Conventional therapeutic methods for &#x3B2;-thalassemia are regular transfusion, chelating therapy and induction of fetal hemoglobin synthesis, iron overload results both transfusional hemosiderosis and excessive gastrointestinal iron absorption, so the characteristic features of advanced iron overload are failure of vital organs such as liver and heart in addition to endocrine dysfunctions.</p>
      <p>Cardiac complications of thalassemia are heart failure, arrhythmias, pericarditis, and including pulmonary hypertension and right heart failure, more intermediate thalassemia have been reported. Cardiac iron overload in patients with thalassemia is particularly important, 71% of deaths in these patients because of cardiac origin, and deaths due to heart failure or arrhythmias associated with sudden death.<xref rid="b3" ref-type="bibr">3</xref></p>
      <p>As the age of the patients and iron loads, has shown a progressive arrhythmias. 22&#x2013;65% of cardiac hemosiderosis patients were analyzed ECG abnormalities. PR prolongation, T-wave abnormalities, low QRS voltage, intraventricular conduction defect, and atrial fibrillation have been reported in patients with thalassemia.<xref rid="b4" ref-type="bibr">4</xref> Twenty-four hour Holter monitoring in patients with iron overload, atrial and ventricular extrasystoles and intermittent episodes of VT were determined.<xref rid="b5" ref-type="bibr">5</xref> Persistent atrial standstill and idioventricular rhythm observed in the literature, cases have been reported in thalassemia intermedia.<xref rid="b6" ref-type="bibr">6</xref></p>
      <p>Kardelen et al. detected that heart rate variability in patients with thalassemia major was seen to be significantly lower than the control group, in the early period the patients with cardiac autonomic neuropathy have been reported.<xref rid="b7" ref-type="bibr">7</xref> In another study, &#x3B2;-thalassemia major patients, secondary to increased sympathetic activation and atrial dilatation, as a result of intra-atrial conduction delay, prolonged P-wave dispersion has been reported.<xref rid="b8" ref-type="bibr">8</xref></p>
      <p>Ventricular arrhythmias, atrial arrhythmias in patients with thalassemia are rare and usually more resistant to antiarrhythmic therapy. Isma'eel et&#xA0;al., the incidence of ventricular late potentials on signal averaged ECG in patients with thalassemia is more than the normal individuals were determined.<xref rid="b9" ref-type="bibr">9</xref> Kocharian et&#xA0;al., QT interval and QT dispersion which predictors of sudden cardiac death were investigated and in patients with thalassemia major is longer than in normal individuals reported.<xref rid="b10" ref-type="bibr">10</xref> These studies in patients with thalassemia, show that the tendency to ventricular arrhythmias increased. Our patient had sustained VT with hemodynamic instability and an ICD implantation was decided for secondary prevention.</p>
    </sec>
    <sec>
      <title>CONCLUSION</title>
      <p>Thalassemia major patients are predisposed to arrhythmias, thus early recognition of cardiac involvement is important for life quality and expectancy of patients.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borgna-Pignatti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cappellini</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>De Stefano</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Survival and complications in thalassemia</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2005</year>
          <volume>1054</volume>
          <fpage>40</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">16339650</pub-id>
        </element-citation>
      </ref>
      <ref id="b2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rund</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rachmilewitz</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Beta-thalassemia</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>353</volume>
          <fpage>1135</fpage>
          <lpage>1146</lpage>
          <pub-id pub-id-type="pmid">16162884</pub-id>
        </element-citation>
      </ref>
      <ref id="b3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ladis</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Chouliaras</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Berdousi H, Kanavakis E, Kattamis C. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2005</year>
          <volume>1054</volume>
          <fpage>445</fpage>
          <lpage>450</lpage>
          <pub-id pub-id-type="pmid">16339695</pub-id>
        </element-citation>
      </ref>
      <ref id="b4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mancuso</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mancuso</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bevacqua</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Electrocardiographic abnormalities in thalassemia patients with heart failure</article-title>
          <source>Cardiovasc Hematol Disord Drug Targets</source>
          <year>2009</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>29</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">19275575</pub-id>
        </element-citation>
      </ref>
      <ref id="b5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cavallaro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Meo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Busa</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Arrhythmia in thalassemia major: Evaluation of iron chelating therapy by dynamic ECG</article-title>
          <source>Minerva Cardioangiol</source>
          <year>1993</year>
          <volume>41</volume>
          <issue>7&#x2013;8</issue>
          <fpage>297</fpage>
          <lpage>301</lpage>
          <pub-id pub-id-type="pmid">8233011</pub-id>
        </element-citation>
      </ref>
      <ref id="b6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heper</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>&#xD6;zensoy</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Korkmaz</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Persistant atrial standstill and idioventricular rhythm in a patient with thalassemia intermedia</article-title>
          <source>Arch Turk Soc Cardiol</source>
          <year>2009</year>
          <volume>37</volume>
          <issue>4</issue>
          <fpage>256</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="b7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kardelen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tezcan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Akcurin</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Heart rate variability in patients with Thalassemia Major</article-title>
          <source>Pediatr Cardiol</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>935</fpage>
          <lpage>939</lpage>
          <pub-id pub-id-type="pmid">18551333</pub-id>
        </element-citation>
      </ref>
      <ref id="b8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nisli</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Taner</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Naci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Electrocardiographic markers for the early detection of cardiac disease in patients with beta-thalassemia major</article-title>
          <source>J Pediatr</source>
          <year>2010</year>
          <volume>86</volume>
          <issue>2</issue>
          <fpage>159</fpage>
          <lpage>162</lpage>
        </element-citation>
      </ref>
      <ref id="b9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isma'eel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shamseddeen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Taher</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Ventricular late potentials among thalassemia patients</article-title>
          <source>Int J Cardiol</source>
          <year>2009</year>
          <volume>132</volume>
          <issue>3</issue>
          <fpage>453</fpage>
          <lpage>455</lpage>
          <pub-id pub-id-type="pmid">18164497</pub-id>
        </element-citation>
      </ref>
      <ref id="b10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kocharian</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rooyfard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aghanouri</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Prolonged dispersion of QT and QTc in thalassemia major patients</article-title>
          <source>Acta Medica Iranica</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>4</fpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
